BRCA2 and neoplasm: Additionally, the concordance rate between tissue and circulating tumor DNA results for BRCA1/BRCA2/ATM mutations in the PROfound test depends on the type of gene mutation (nonsense mutations and frameshift mutations have high concordance rates, gene rearrangements, and poor concordance for conjugative loss) and is generally favorable [28].